Search company, investor...
Sai Life Sciences company logo

Sai Life Sciences

sailife.com

Founded Year

1999

Stage

Private Equity | Alive

About Sai Life Sciences

Sai Life Sciences offers their clients a wide range of integrated drug discovery, development and formulation services, with core expertise founded in synthetic, medicinal and process chemistry and further augmented by a suite of preclinical support services including DMPK, toxicology and formulation that are continually expanding to meet clients' needs.

Headquarters Location

#8-2-120/86/9/B, Luxor Park Road No.2, Banjara Hills

Hyderabad, 500 033,

India

+91 40 6677 7555

Missing: Sai Life Sciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Sai Life Sciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Sai Life Sciences Patents

Sai Life Sciences has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/23/2012

Molding processes, Brazing and soldering, Archaeological artefact types, Lithics, Ceramic materials

Application

Application Date

10/23/2012

Grant Date

Title

Related Topics

Molding processes, Brazing and soldering, Archaeological artefact types, Lithics, Ceramic materials

Status

Application

Latest Sai Life Sciences News

04:00 ET Stephen Hermitage joins Sai Life Sciences as VP, CMC

Nov 22, 2022

USA - English Share this article Share this article MANCHESTER, England and HYDERABAD, India, Nov. 22, 2022 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organisation (CRO-CDMO) , today announced the joining of Stephen Hermitage (Steve) as Vice President, CMC. In this role Steve will join the global R&D leadership team at Sai Life Sciences, where he will add further deep scientific, process development and drug development experience to the R&D organisation. Stephen Hermitage joins Sai Life Sciences as VP, CMC Making the announcement, Sauri Gudlavalleti, Chief Operating Officer said, "Over the past few years, our team has established a formidable reputation for itself as a high-quality scientific unit that can solve complex chemistry challenges. I am delighted to welcome Steve, a pharma industry veteran, onboard at Sai Life Sciences. His addition to our global delivery team further strengthens our ongoing efforts to build strong client partnerships and exceed client expectations by raising the bar on innovation, speed, and efficiency. Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team. Over 24 years at GSK Steve has successfully worked with many project leaders and their teams to deliver the API and regulatory submissions that facilitate preclinical and clinical activities across the whole development lifecycle - from pragmatic accelerated early phase supply to complex Quality by Design (QbD) control strategies supporting commercial file and launch. Throughout his time with GSK Steve gained significant experience of working with CDMOs in India , China and Europe having led the technical externalisation group within Chemical Development. Elaborating on Steve's role, Dean Edney, Global Head of Process R&D said, "Steve will bring best practices in late phase chemical and API development  to programs across Manchester and Hyderabad. His experience will also provide new perspectives on project and program management, ensuring we continue to build towards excellence in client partnership." Steve holds a BA & MA from Oxford University, a PhD from Liverpool University and conducted Postdoc studies at the University of Cambridge. He is a Fellow of the Royal Society of Chemistry and Chartered Chemist (FRSC CChem). Commenting on his appointment, Steve Hermitage said, "I am incredibly excited to join Sai Life Sciences at a transformative time for the company. Throughout all my interactions with colleagues in the company it is clear that there is a collective ambition to build a world leading organisation that delivers Projects for customers by blending strong science with efficient manufacturing capability whilst maintaining high standards in Safety and Quality." About Sai Life Sciences Sai Life Sciences is a full-service CRO-CDMO  that works with innovator pharma and biotech companies globally, to accelerate the discovery, development and commercialisation of complex small molecules. The company has over 2200 employees across its facilities in India, UK and USA. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments. https://www.sailife.com/

Sai Life Sciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sai Life Sciences Rank

Sai Life Sciences Frequently Asked Questions (FAQ)

  • When was Sai Life Sciences founded?

    Sai Life Sciences was founded in 1999.

  • Where is Sai Life Sciences's headquarters?

    Sai Life Sciences's headquarters is located at #8-2-120/86/9/B, Luxor Park, Hyderabad.

  • What is Sai Life Sciences's latest funding round?

    Sai Life Sciences's latest funding round is Private Equity.

  • Who are the investors of Sai Life Sciences?

    Investors of Sai Life Sciences include TPG Capital, MPM Capital, Sequoia Capital and Sequoia Capital India.

  • Who are Sai Life Sciences's competitors?

    Competitors of Sai Life Sciences include United BioSource, ADMA Biologics, Austrianova, Altarum Institute, Aurora Analytics, Biocrates Life Sciences, Frontage Laboratories, Pharmaron, WuXi AppTec, Asterand Bioscience and 26 more.

Compare Sai Life Sciences to Competitors

M
Micromyx

Micromyx is a microbiology services company engaged in anti-infective discovery and development for the pharmaceutical, biotechnology, and animal health industries. Founded in 2004 by former pharmaceutical industry infectious disease scientists, Micromyx is a contract research organization that aims to offer clients documented, top-of-the-line laboratory services from experts who have successfully gained FDA approval of new antibiotics.

P
Pacific Data Designs

ClinOps, LLC, is a focused contract research organization serving the Biotechnology, Pharmaceutical and Medical Device industries and specializes in data management, SAS/statistical analysis services, and investigatorinitiated study management. The company are committed to being a bestinclass partner to the company's clients by using the company's unparalleled core competencies to advance and accelerate their therapeutic clinical development initiatives.

R
Renovo Research

Renovo Research is a contract research lab that specializes in crystal form discovery for the pharmaceutical industry.

C
Clinical Trials of the Americas

The company provide clinical research services to area physicians in a range of therapeutic specialties and contract with pharmaceutical companies and contract research organizations (CROs) to conduct in-patient clinical research. The company have successfully conducted more than 500 Phase I, II, III, and IV clinical trials and utilize the Clinasyst Software  System for trial management with a database of greater than 40,000 subjects.

C
CRO services

CRO stands for Contract Research Organization, which takes part in clinical trial operations conducted by pharmaceutical companies or other entities. The company at TMRC Co., Ltd. provide monitoring, data management and other related operations engaged in cancers, to major pharmaceutical companies.

E
ElexoPharm

ElexoPharm is a German biotech company, founded as a spin-off of the Department of Pharmaceutical and Medicinal Chemistry of Saarland University. ElexoPharm is focused on the preclinical discovery and optimization of drugs for human diseases, which are currently not or insufficiently treatable with existing drugs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.